Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals

Ceftazidime-avibactam (CZA) is the combination of a third-generation cephalosporin and a new non-β-lactam β-lactamase inhibitor capable of inactivating class A, C, and some D β-lactamases. From a collection of 2,727 clinical isolates of Enterobacterales (n = 2,235) and P. aeruginosa (n = 492) that w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mojica, María Fernanda, De La Cadena, Elsa, García-Betancur, Juan Carlos, Porras, Jessica, Novoa-Caicedo, Isabella, Páez-Zamora, Laura, Pallares, Christian, Appel, Tobias Manuel, Radice, Marcela A., Castañeda-Méndez, Paulo, Gales, Ana C., Munita, José M., Villegas, María Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117078/
https://www.ncbi.nlm.nih.gov/pubmed/36877058
http://dx.doi.org/10.1128/msphere.00651-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117078/
https://www.ncbi.nlm.nih.gov/pubmed/36877058
http://dx.doi.org/10.1128/msphere.00651-22

Ejemplares similares